Wain, K.E.; Tolwinski, K.; Palen, E.; Heidlebaugh, A.R.; Holdren, K.; Walsh, L.K.; Oetjens, M.T.; Ledbetter, D.H.; Martin, C.L.
Population Genomic Screening for Genetic Etiologies of Neurodevelopmental/Psychiatric Disorders Demonstrates Personal Utility and Positive Participant Responses. J. Pers. Med. 2021, 11, 365.
https://doi.org/10.3390/jpm11050365
AMA Style
Wain KE, Tolwinski K, Palen E, Heidlebaugh AR, Holdren K, Walsh LK, Oetjens MT, Ledbetter DH, Martin CL.
Population Genomic Screening for Genetic Etiologies of Neurodevelopmental/Psychiatric Disorders Demonstrates Personal Utility and Positive Participant Responses. Journal of Personalized Medicine. 2021; 11(5):365.
https://doi.org/10.3390/jpm11050365
Chicago/Turabian Style
Wain, Karen E., Kasia Tolwinski, Emily Palen, Alexis R. Heidlebaugh, Karahlyn Holdren, Lauren Kasparson Walsh, Matthew T. Oetjens, David H. Ledbetter, and Christa Lese Martin.
2021. "Population Genomic Screening for Genetic Etiologies of Neurodevelopmental/Psychiatric Disorders Demonstrates Personal Utility and Positive Participant Responses" Journal of Personalized Medicine 11, no. 5: 365.
https://doi.org/10.3390/jpm11050365
APA Style
Wain, K. E., Tolwinski, K., Palen, E., Heidlebaugh, A. R., Holdren, K., Walsh, L. K., Oetjens, M. T., Ledbetter, D. H., & Martin, C. L.
(2021). Population Genomic Screening for Genetic Etiologies of Neurodevelopmental/Psychiatric Disorders Demonstrates Personal Utility and Positive Participant Responses. Journal of Personalized Medicine, 11(5), 365.
https://doi.org/10.3390/jpm11050365
